Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buffa

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
Radiation Research|July 20, 2007
Dose- and time-dependent changes in gene expression in human glioma cells after low radiation dosesS C Short, F M Buffa, S Bourne, et al.
Cancer Biology & Therapy|May 12, 2017
Depletion of signal recognition particle 72kDa increases radiosensitivityRemko Prevo, Gaganpreet S Tiwana, Timothy S Maughan, et al.
Oncotarget|February 19, 2015
Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancerWing-yin Leung, Ioannis Roxanis, Helen Sheldon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2006
Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapyGeorge D Wilson, Michele I Saunders, Stanley Dische, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapyFrancesca M Buffa, Søren M Bentzen, Frances M Daley, et al.
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Radiation Research|July 20, 2007
Dose- and time-dependent changes in gene expression in human glioma cells after low radiation dosesS C Short, F M Buffa, S Bourne, et al.
Cancer Biology & Therapy|May 12, 2017
Depletion of signal recognition particle 72kDa increases radiosensitivityRemko Prevo, Gaganpreet S Tiwana, Timothy S Maughan, et al.
Oncotarget|February 19, 2015
Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancerWing-yin Leung, Ioannis Roxanis, Helen Sheldon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2006
Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapyGeorge D Wilson, Michele I Saunders, Stanley Dische, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapyFrancesca M Buffa, Søren M Bentzen, Frances M Daley, et al.
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
Pageof 14